es2 cell line Search Results


cdna prepared from rna extracted from ovary cell line es2  (BioChain Institute)
90
BioChain Institute cdna prepared from rna extracted from ovary cell line es2
Cdna Prepared From Rna Extracted From Ovary Cell Line Es2, supplied by BioChain Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/es2+cell+line/us07678769-1205-39-71?v=BioChain+Institute
Average 90 stars, based on 1 article reviews
cdna prepared from rna extracted from ovary cell line es2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
es2  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection es2
Figure 1. Inhibition of EZH2 decreases BRCA1 mRNA level but increases BRCA1 protein level. (A) The mRNA level of BRCA1 was decreased in shEZH2 transfected cells compared with untransfected <t>ES2,</t> SKOV3, and A2780 cells. (B) Immunoblot assays revealed that total protein expression of BRCA1 was increased in stable transfected shEZH2-A2780 cells. (C) Left, loss of EZH2 increased BRCA1 nuclear protein level, but decreased BRCA1 cytoplasmic protein level. N and C represent nuclear and cytoplasmic protein respectively. Right, quantization of western blot. (D) Immunocytochemistry analysis shown that stable inhibition of EZH2 in A2780 cells increased BRCA1 protein expression and induced BRCA1 nuclear localization (×400).
Es2, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/es2+cell+line/pmc03974828-194-10-14?v=China+Center+for+Type+Culture+Collection
Average 90 stars, based on 1 article reviews
es2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
ovarian cell line es-2  (Genentech inc)
90
Genentech inc ovarian cell line es-2
Figure 1. Inhibition of EZH2 decreases BRCA1 mRNA level but increases BRCA1 protein level. (A) The mRNA level of BRCA1 was decreased in shEZH2 transfected cells compared with untransfected <t>ES2,</t> SKOV3, and A2780 cells. (B) Immunoblot assays revealed that total protein expression of BRCA1 was increased in stable transfected shEZH2-A2780 cells. (C) Left, loss of EZH2 increased BRCA1 nuclear protein level, but decreased BRCA1 cytoplasmic protein level. N and C represent nuclear and cytoplasmic protein respectively. Right, quantization of western blot. (D) Immunocytochemistry analysis shown that stable inhibition of EZH2 in A2780 cells increased BRCA1 protein expression and induced BRCA1 nuclear localization (×400).
Ovarian Cell Line Es 2, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/es2+cell+line/pm25838397-105-0-9?v=Genentech+inc
Average 90 stars, based on 1 article reviews
ovarian cell line es-2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
es-2 cell line  (Hengyu Inc)
90
Hengyu Inc es-2 cell line
Figure 1. Inhibition of EZH2 decreases BRCA1 mRNA level but increases BRCA1 protein level. (A) The mRNA level of BRCA1 was decreased in shEZH2 transfected cells compared with untransfected <t>ES2,</t> SKOV3, and A2780 cells. (B) Immunoblot assays revealed that total protein expression of BRCA1 was increased in stable transfected shEZH2-A2780 cells. (C) Left, loss of EZH2 increased BRCA1 nuclear protein level, but decreased BRCA1 cytoplasmic protein level. N and C represent nuclear and cytoplasmic protein respectively. Right, quantization of western blot. (D) Immunocytochemistry analysis shown that stable inhibition of EZH2 in A2780 cells increased BRCA1 protein expression and induced BRCA1 nuclear localization (×400).
Es 2 Cell Line, supplied by Hengyu Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/es2+cell+line/pm25483088-99-0-34?v=Hengyu+Inc
Average 90 stars, based on 1 article reviews
es-2 cell line - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
ovarian cancer cell line es-2  (iCell Gene Therapeutics)
90
iCell Gene Therapeutics ovarian cancer cell line es-2
Tumorigenicity test of orthotopic transplantation of MSCs. A Flowchart overview of the establishment of an orthotopic xenograft tumour model in mice. B Flowchart overview of the evaluation of the tumorigenic potential of MSC transplantation. C Photographs and pathological section images of xenograft tumours established in situ. D Representative image of mice in the <t>ES-2</t> injection group. E Photographs of ovaries in the AD-MSC injection group. F Photographs of ovaries in the UC-MSC injection group. G Representative pathological images of ovaries and other organs in the MSC transplantation group
Ovarian Cancer Cell Line Es 2, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/es2+cell+line/pmc10988907-55-1-6?v=iCell+Gene+Therapeutics
Average 90 stars, based on 1 article reviews
ovarian cancer cell line es-2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
es-2 cell line  (Elabscience Biotechnology)
N/A
ES-2 Cell Line
   Buy from Supplier
es 2 cell line  (Elabscience)
N/A
   Buy from Supplier
es2 gfp and luciferase reporter cell line  (AcceGen Biotechnology)
N/A
The ES2 Luciferase GFP cell line is transformed from ES2 cell, expressing the GFP and luciferase gene. The cell constitutively express GFP and luciferase.
   Buy from Supplier
es2 rfp and luciferase reporter cell line  (AcceGen Biotechnology)
N/A
The ES2 Luciferase RFP cell line is transformed from ES2 cell, expressing the firefly luciferase and RFP gene. The cell constitutively express Luciferase and RFP.
   Buy from Supplier

Image Search Results


Figure 1. Inhibition of EZH2 decreases BRCA1 mRNA level but increases BRCA1 protein level. (A) The mRNA level of BRCA1 was decreased in shEZH2 transfected cells compared with untransfected ES2, SKOV3, and A2780 cells. (B) Immunoblot assays revealed that total protein expression of BRCA1 was increased in stable transfected shEZH2-A2780 cells. (C) Left, loss of EZH2 increased BRCA1 nuclear protein level, but decreased BRCA1 cytoplasmic protein level. N and C represent nuclear and cytoplasmic protein respectively. Right, quantization of western blot. (D) Immunocytochemistry analysis shown that stable inhibition of EZH2 in A2780 cells increased BRCA1 protein expression and induced BRCA1 nuclear localization (×400).

Journal: Cancer Biology & Therapy

Article Title: EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1

doi: 10.4161/cbt.27306

Figure Lengend Snippet: Figure 1. Inhibition of EZH2 decreases BRCA1 mRNA level but increases BRCA1 protein level. (A) The mRNA level of BRCA1 was decreased in shEZH2 transfected cells compared with untransfected ES2, SKOV3, and A2780 cells. (B) Immunoblot assays revealed that total protein expression of BRCA1 was increased in stable transfected shEZH2-A2780 cells. (C) Left, loss of EZH2 increased BRCA1 nuclear protein level, but decreased BRCA1 cytoplasmic protein level. N and C represent nuclear and cytoplasmic protein respectively. Right, quantization of western blot. (D) Immunocytochemistry analysis shown that stable inhibition of EZH2 in A2780 cells increased BRCA1 protein expression and induced BRCA1 nuclear localization (×400).

Article Snippet: Three human epithelial ovarian cancer cell lines, A2780, SKOV3, and ES2 were purchased from China Center for Type Culture Collection (CCTCC).

Techniques: Inhibition, Transfection, Western Blot, Expressing, Immunocytochemistry

Figure 2. Depletion of BRCA1 partially rescues the biological effects of EZH2 inhibition in ovarian cancer. (A and B) The efficiencies of siBRCA1s silencing in A2780 cells were detected at mRNA (A) and protein (B) levels by qRT-PCR and western blotting respectively. (C) The shEZH2-mediated BRCA1 overexpression was abolished by cotransfection of siBRCA1-2 or -3. (D) Quantization of western blot. (E and F) Cell proliferation and cell cycle analyses were detected by MTT assay and flow cytometry respectively; showing that cotransfection of siBRCA1 partly rescued the reduction in cell proliferation and depressed the elevated percentage of G2/M phase caused by shEZH2 transfection in A2780 and ES2 cells. (G) Transwell migration assays revealed that inhibition of BRCA1 inversed the suppression in cell migration in A2780 and ES2 cells with shEZH2 transfection (×200).

Journal: Cancer Biology & Therapy

Article Title: EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1

doi: 10.4161/cbt.27306

Figure Lengend Snippet: Figure 2. Depletion of BRCA1 partially rescues the biological effects of EZH2 inhibition in ovarian cancer. (A and B) The efficiencies of siBRCA1s silencing in A2780 cells were detected at mRNA (A) and protein (B) levels by qRT-PCR and western blotting respectively. (C) The shEZH2-mediated BRCA1 overexpression was abolished by cotransfection of siBRCA1-2 or -3. (D) Quantization of western blot. (E and F) Cell proliferation and cell cycle analyses were detected by MTT assay and flow cytometry respectively; showing that cotransfection of siBRCA1 partly rescued the reduction in cell proliferation and depressed the elevated percentage of G2/M phase caused by shEZH2 transfection in A2780 and ES2 cells. (G) Transwell migration assays revealed that inhibition of BRCA1 inversed the suppression in cell migration in A2780 and ES2 cells with shEZH2 transfection (×200).

Article Snippet: Three human epithelial ovarian cancer cell lines, A2780, SKOV3, and ES2 were purchased from China Center for Type Culture Collection (CCTCC).

Techniques: Inhibition, Quantitative RT-PCR, Western Blot, Over Expression, Cotransfection, MTT Assay, Flow Cytometry, Transfection, Migration

Tumorigenicity test of orthotopic transplantation of MSCs. A Flowchart overview of the establishment of an orthotopic xenograft tumour model in mice. B Flowchart overview of the evaluation of the tumorigenic potential of MSC transplantation. C Photographs and pathological section images of xenograft tumours established in situ. D Representative image of mice in the ES-2 injection group. E Photographs of ovaries in the AD-MSC injection group. F Photographs of ovaries in the UC-MSC injection group. G Representative pathological images of ovaries and other organs in the MSC transplantation group

Journal: Stem Cell Research & Therapy

Article Title: Efficacy and safety of mesenchymal stem cell therapy for ovarian ageing in a mouse model

doi: 10.1186/s13287-024-03698-0

Figure Lengend Snippet: Tumorigenicity test of orthotopic transplantation of MSCs. A Flowchart overview of the establishment of an orthotopic xenograft tumour model in mice. B Flowchart overview of the evaluation of the tumorigenic potential of MSC transplantation. C Photographs and pathological section images of xenograft tumours established in situ. D Representative image of mice in the ES-2 injection group. E Photographs of ovaries in the AD-MSC injection group. F Photographs of ovaries in the UC-MSC injection group. G Representative pathological images of ovaries and other organs in the MSC transplantation group

Article Snippet: The ovarian cancer cell line ES-2 (iCell-h060, iCell) was used as a positive control for tumorigenicity detection.

Techniques: Transplantation Assay, In Situ, Injection